MetaCap

EnerSyn Global Inc. (ESYN)

NASDAQ: ESYNHealth CareOther PharmaceuticalsUSD

1.11-0.01 (-0.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ESYN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$37.44M
EPS (TTM)
-$0.58
52-week range
0.88 – 2.81
Day range
1.05 – 1.17
Volume / Avg
9.72K / 38.17K
Beta
—

52-week range

$0.88$2.81

ESYN stock today

Shares of EnerSyn Global (ESYN) finished lower on Nov 20 at $1.11, a drop of 0.89% or $0.01 per share, versus the S&P 500's 3.70% decline. Trading was light, with 9.72K shares changing hands, about 25% of the average daily volume. Shares are 60.5% below their 52-week high of $2.81, set on Dec 8, 2025 and 26.1% above the 52-week low of $0.88, near the bottom of the past year's range.

ESYN is down 25.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 26.5%. EnerSyn Global has posted a net loss over the last twelve months (EPS of -$0.58), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About EnerSyn Global

Company profile

EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea. The company provides Hapi Café, a health-focused dining destination offering a various nutritious meal, including Keto and plant-based options; Hapi Marketplace, a business-to-consumer platform featuring diverse product categories; and Hapi Wealth Builder, an educational program focused on wealth-building strategies; and provides participants the opportunity to attend courses, workshops, and coaching sessions in person fostering a collaborative learning environment for those dedicated to learning about investment in equities and wealth-building strategies.

Industry
Other Pharmaceuticals
CEO
Dr. Ming Xing Liu
Headquarters
Bethesda, MD
Employees
4
IPO year
2022

Financial highlights

Full financials

In fiscal 2025, EnerSyn Global generated $866,926 in revenue, down 30.8% from fiscal 2024, the first decline in the 5 years shown. EnerSyn Global reported a net loss of $2.6 million, compared with a loss of $2.7 million a year earlier. Gross margin was 53.0% (up from 48.0%).

EnerSyn Global annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2023FY 2022
Revenue$866.93K$1.25M$1.18K——
Growth-30.84%+105776.44%———
Net income$-2.63M$-2.75M$-1.08M$548.87K$113.54K
EPS (diluted)$-0.40$-0.76———

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$-0.15 vs —

EnerSyn Global peers

Health Care sector
ESYN peer companies
CompanyPrice% ChgMarket capCompare
COSMCosmos Health Inc.2.81-2.09%$14.14Mvs ESYN
MEDSDataMeds AI Inc.1.34+84.14%$7.67Mvs ESYN
HKPDCellyan Biotechnology Co. Ltd Class A1.38+2.60%$3.40Mvs ESYN
NUSNu Skin Enterprises Inc.3.80+0.80%$184.98Mvs ESYN
HLFHerbalife Ltd.15.53-0.26%$1.63Bvs ESYN
CAHCardinal Health Inc.272.81+0.17%$63.06Bvs ESYN
CORCencora Inc.339.09-0.63%$64.71Bvs ESYN
MCKMcKesson Corporation1,069.43+0.68%$123.47Bvs ESYN

Indexes, lists and sector

EnerSyn Global stock FAQ

What is EnerSyn Global's stock price today?

ESYN last traded at $1.11 as of Nov 20, 4:00 PM EST, down 0.89% on the day. Prices are delayed at least 15 minutes.

Does EnerSyn Global pay a dividend?

No. EnerSyn Global does not currently pay a regular cash dividend.

Who is EnerSyn Global's CEO?

Dr. Ming Xing Liu is the chief executive officer of EnerSyn Global Inc., which has about 4 employees.

Has ESYN ever split its stock?

Yes. The most recent ESYN stock split was a 1-for-5 split on Feb 24, 2025.

What is the ESYN 52-week high?

The 52-week high for ESYN is $2.81 and the 52-week low is $0.88. The stock is currently 60.5% below its high.

Compare ESYN